IKT Operating Cash Flow (Statement)
Inhibikase Therapeutics Inc · Operating Cash Flow (Statement)
IKT Operating Cash Flow (Statement)
Latest reported-$12.44Mperiod ending
IKT Quarterly Cash from Operations ($94.10K → -$12.44M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
IKT operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -12,443,612 | |
| -12,059,722 | |
| -7,515,973 | |
| -10,592,730 | |
| -5,574,231 | |
| -4,103,530 | |
| -5,345,575 | |
| -4,881,100 | |
| -5,054,374 | |
| -3,867,018 | |
| -3,442,431 | |
| -4,105,093 | |
| -4,565,389 | |
| -5,972,130 | |
| -3,556,374 | |
| -5,504,730 | |
| -4,355,802 | |
| -3,934,197 | |
| -4,095,817 | |
| -2,020,498 | |
| -4,246,516 | |
| -3,934,220 | |
| -946,528 | |
| 75,515 | |
| -10,669 | |
| -255,432 | |
| 6,373 | |
| -6,801 | |
| -49,140 | |
| -288,722 | |
| 63,952 | |
| 94,098 |